Abstract

Merkel Cell Polyomavirus (MCV or MCPyV) was recently discovered in an aggressive form of skin cancer known as Merkel cell carcinoma (MCC). Integration of MCV DNA into the host genome likely contributes to the development of MCC in humans. MCV infection is common and many healthy people shed MCV virions from the surface of their skin. MCV DNA has also been detected in samples from a variety of other tissues. Although MCC tumors serve as a record that MCV can infect the Merkel cell lineage, the true tissue tropism and natural reservoirs of MCV infection in the host are not known. In an effort to gain insight into the tissue tropism of MCV, and to possibly identify cellular factors responsible for mediating infectious entry of the virus, the infection potential of human cells derived from a variety of tissues was evaluated. MCV gene transfer vectors (pseudoviruses) carrying reporter plasmid DNA encoding GFP or luciferase genes were used to transduce keratinocytes and melanocytes, as well as lines derived from MCC tumors and the NCI-60 panel of human tumor cell lines. MCV transduction was compared to transduction with pseudoviruses based on the better-studied human BK polyomavirus (BKV). The efficiency of MCV and BKV transduction of various cell types occasionally overlapped, but often differed greatly, and no clear tissue type preference emerged. Application of native MCV virions to a subset of highly transducible cell types suggested that the lines do not support robust replication of MCV, consistent with recent proposals that the MCV late phase may be governed by cellular differentiation in vivo. The availability of carefully curated gene expression data for the NCI-60 panel should make the MCV and BKV transduction data for these lines a useful reference for future studies aimed at elucidation of the infectious entry pathways of these viruses.

Highlights

  • Polyomaviruses have a long history as suspected agents underlying various cancers in humans

  • Not until the discovery of Merkel cell polyomavirus (MCV or MCPyV) in a rare form of skin cancer, known as Merkel cell carcinoma (MCC), has conclusive evidence been brought in support of a causal relationship of a polyomavirus to cancer in human populations

  • Since gene expression profiles are likely to be sensitive to culture conditions, the procedures and reagents used by the Developmental Therapeutics Program (DTP) were mimicked as much as possible when culturing and plating cells

Read more

Summary

Introduction

Polyomaviruses have a long history as suspected agents underlying various cancers in humans. Not until the discovery of Merkel cell polyomavirus (MCV or MCPyV) in a rare form of skin cancer, known as Merkel cell carcinoma (MCC), has conclusive evidence been brought in support of a causal relationship of a polyomavirus to cancer in human populations. Like other human polyomaviruses, such as BK polyomavirus (BKV or BKPyV), infection by MCV appears to be widespread. BKV was discovered more than four decades ago in the urine of a kidney transplant recipient [7]. BKV can cause cancer in experimentally-exposed animals, conclusive evidence of a fundamental role for BKV as a causal agent underlying human cancer is lacking (reviewed in [11]).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call